RecruitingNCT06393920
PulseSelect™ PFA Global Registry
PulseSelect PFA Global Registry, a Part of the Medtronic Cardiac Ablation Post-Market Study Platform
Sponsor
Medtronic Cardiac Ablation Solutions
Enrollment
1,950 participants
Start Date
Jul 23, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
The PulseSelect™ PFA Global Registry is a prospective, global, multi-center, observational post-approval study. Subjects will be treated with the PulseSelect™ PFA System and followed according to SOC.
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- Subject is ≥ 18 years of age or minimum age as required by local regulations.
- Subject has been diagnosed with atrial fibrillation (AF)
- Planned procedure using commercially available PulseSelect™ PFA System.
- Willing to comply with study requirements and give informed consent (defined as legally effective, documented confirmation of a subject's voluntary agreement to participate in this clinical study) or authorization per institution and geographical requirements.
Exclusion Criteria1
- Subject is enrolled in a concurrent study that has not been approved for concurrent enrollment by the global study manager.
Locations(28)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06393920
Related Trials
The CONFORM Pivotal Trial
NCT0514779283 locations
A Registry on the FARAVIEW Technology of the OPAL HDx Mapping System When Used With the FARAWAVE NAV Ablation Catheter in the Treatment of Atrial Fibrillation
NCT0680821732 locations
A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System
NCT072275327 locations
A Study of Assessment on Safety and Effectiveness of BWI Pulsed Field Ablation With OMNYPULSE Catheter for the Treatment of Paroxysmal Atrial Fibrillation (PAF)
NCT0645509846 locations
The Fourth Left Atrial Appendage Occlusion Study
NCT05963698127 locations